These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9313072)

  • 21. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical venous pressure in normal, growth-retarded, and anemic fetuses.
    Ville Y; Sideris I; Hecher K; Snijders RJ; Nicolaides KH
    Am J Obstet Gynecol; 1994 Feb; 170(2):487-94. PubMed ID: 8116702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma atrial natriuretic peptide in human fetus: response to intravascular blood transfusion.
    Panos MZ; Nicolaides KH; Anderson JV; Economides DL; Rees L; Williams R
    Am J Obstet Gynecol; 1989 Aug; 161(2):357-61. PubMed ID: 2527463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravascular fetal transfusion in the management of perinatal hemolytic disease].
    Oyarzún E; Gormaz G; Robert JA; González P; Cossio A; Tsunekawa H
    Rev Chil Obstet Ginecol; 1991; 56(3):181-7; discussion 187-8. PubMed ID: 1845084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization.
    Moise KJ; Deter RL; Kirshon B; Adam K; Patton DE; Carpenter RJ
    Obstet Gynecol; 1989 Dec; 74(6):905-8. PubMed ID: 2586956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G; Soncini CS
    Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

  • 30. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective non-invasive monitoring of pregnancies complicated by red cell alloimmunization.
    Iskaros J; Kingdom J; Morrison JJ; Rodeck C
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):432-7. PubMed ID: 9674091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.
    Zwiers C; Lindenburg ITM; Klumper FJ; de Haas M; Oepkes D; Van Kamp IL
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):180-186. PubMed ID: 27706858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
    Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
    Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in fetal myocardial performance index following intravascular transfusion: preliminary report.
    de Assunção RA; Liao AW; Brizot Mde L; Francisco RP; Zugaib M
    J Matern Fetal Neonatal Med; 2016; 29(16):2697-702. PubMed ID: 26421506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization.
    Goodrum LA; Saade GR; Belfort MA; Carpenter RJ; Moise KJ
    Obstet Gynecol; 1997 Jan; 89(1):57-60. PubMed ID: 8990438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.